About Applied Biosystems
Applied Biosystems is a company based in Newport Beach (United States) founded in 1997 was acquired by Invitrogen in June 2008. Applied Biosystems offers products and services including TaqMan Real-Time PCR Assays, Digital PCR, Sanger Sequencing, and Microarray Analysis. Applied Biosystems operates in a competitive market with competitors including Abcam, Arbor Biotechnologies, Singleron, Octant and Stem Cell Technologies, among others.
- Headquarter Newport Beach, United States
- SectorsHealthcare
- Website appliedbiosystems.com
- Social LinkedIn Facebook
- Acquired by Invitrogen (Jun 2008)
- Investors
- Acquired byInvitrogen
(Jun 2008)
Products & Services of Applied Biosystems
Applied Biosystems offers a comprehensive portfolio of products and services, including TaqMan Real-Time PCR Assays, Digital PCR, Sanger Sequencing, and Microarray Analysis.
Enables real-time PCR for genetic testing and expression analysis.
Provides precise molecular counting for gene expression detection.
Offers capillary electrophoresis for DNA fragment analysis.
Supports researchers with products for gene expression studies.
Investors in Applied Biosystems
Applied Biosystems has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Invitrogen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of scientific instruments, services, and consumables | 1987 | invitrogen.com | Carlsbad, United States |
Investor details for Applied Biosystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Applied Biosystems
2 dated milestones of Applied Biosystems across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Applied Biosystems is founded.
- Exit Acquired by Invitrogen.
Competitors of Applied Biosystems
Applied Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Arbor Biotechnologies, Singleron, Octant and Stem Cell Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| arbor.bio | 2016 | Cambridge, United States | $304.1M | 117 | Genomic technologies and drug discovery platforms are provided. | |
| singleron.bio | 2018 | Hagen, Germany | $84.48M | – | Developer of single-cell multi-omics platform for clinical research and molecular diagnosis | |
| octant.bio | 2017 | Los Angeles, United States | $110M | 63 | Human cell interaction platform is provided for drug discovery. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits |
Detailed competitors of Applied Biosystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Applied Biosystems
Websites that share an audience with Applied Biosystems (appliedbiosystems.com).
Websites whose visitors overlap most with Applied Biosystems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lifetechnologies.com | 100% | – | – | View details | |
| invitrogen.com | 100% | 5.2K | #3,688,642 | View details | |
amebioscience.com | amebioscience.com | 100% | – | – | – |
promega.com | promega.com | 100% | – | #192,389 | – |
| illumina.com | 99% | 672.7K | #61,793 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 26 similar websites and full traffic analytics for Applied Biosystems
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 26 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Applied Biosystems
10 companies that operate in the same segment as Applied Biosystems (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Applied Biosystems
Applied Biosystems was founded in 1997.
Applied Biosystems is headquartered in Newport Beach, United States. It is registered at Newport Beach, California, United States.
Applied Biosystems was founded in 1997 and is headquartered in Newport Beach, United States. Operations focus on the life science research sector, where instruments, assays, and reagents are developed and distributed. Key products include the SOLiD next-generation sequencers, capillary electrophoresis systems, Real-Time and traditional PCR systems, flow cytometers, and TaqMan assays. Consumables for these instruments are also manufactured to support research applications.
Applied Biosystems's top competitors include Abcam, Arbor Biotechnologies and Meridian Bioscience.
Applied Biosystems offers TaqMan Real-Time PCR Assays, Digital PCR, Sanger Sequencing, and Microarray Analysis.
Applied Biosystems has 1 investor. Key investors include Invitrogen.
Yes. Applied Biosystems was acquired by Invitrogen in June 2008.